Dyne Therapeutics Announces Proposed Public Offering of Common Stock

January 3, 2024

https://www.globenewswire.com/news-release/2024/01/03/2803640/0/en/Dyne-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html

WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that it has commenced an underwritten public offering of $175,000,000 of shares of its common stock. Dyne also intends to grant the underwriters a 30-day option to purchase up to an additional $26,250,000 of shares of its common stock. All of the shares in the proposed offering are to be sold by Dyne.

Read more at globenewswire.com

Related news for (DYN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.